Investing Profile

Edward Van Wezel

InvestorVC
Managing Partner at BGV (BioGeneration Ventures)
Photo of Edward Van Wezel, Managing Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $1M
$500K
7
€250M
CompanyStageDateRound SizeTotal Raised
Citryll
Series BDec 2024$90M
Series BJul 2020$21M
$110M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Geert-Jan Mulder (Forbion), Isabelle de Cremoux (Seventure Partners)
Confo Therapeutics
Series BJul 2024$65M
Series AMay 2019$34M
$99M
Azafaros
Series AFeb 2020$27M
SeedJul 2018
$27M
Co-investors: Sander Slootweg (Forbion)
Noviogendix Holding
Series UnknownJan 2007